Literature DB >> 11882917

Supersensitivity of 5-HT1A autoreceptors and alpha2-adrenoceptors regulating monoamine synthesis in the brain of morphine-dependent rats.

Antoni Sastre-Coll1, Susana Esteban, Jesús A García-Sevilla.   

Abstract

The sensitivity of 5-HT1A serotonin receptors and alpha2-adrenoceptors (autoreceptors and heteroreceptors) modulating brain monoamine synthesis was investigated in rats during morphine treatment and after naloxone-precipitated withdrawal. The accumulation of 5-hydroxytryptophan (5-HTP) and 3,4-dihydroxyphenylalanine (DOPA) after decarboxylase inhibition was used as a measure of the rate of tryptophan and tyrosine hydroxylation in vivo. Acute morphine (3-100 mg/kg, 1 h) increased the synthesis of 5-HTP/5-HT in various brain regions (15%-35%) and that of DOPA/dopamine (DA) in striatum (28%-63%), but decreased the synthesis of DOPA/noradrenaline (NA) in hippocampus and cortex (20%-33%). Naloxone (2-60 mg/kg, 1 h) did not alter the synthesis of 5-HTP or DOPA in brain. Tolerance to the inhibitory effect of morphine on DOPA/NA synthesis and a sensitization to its stimulatory effects on DOPA/DA and 5-HTP/5-HT synthesis were observed after chronic morphine and/or in morphine-withdrawn rats. In morphine-dependent rats (tolerant and withdrawn states) the inhibitory effects of the 5-HT1A agonists 8-OH-DPAT and buspirone (0.1 mg/kg, 1 h), and that of the alpha2-adrenoceptor agonist clonidine (0.1 mg/kg, 1 h), on the synthesis of 5-HTP/5-HT were potentiated (25%-50%). Moreover, the effect of 8-OH-DPAT was antagonized by WAY 100135, a selective 5-HT1A antagonist. In morphine-dependent rats (tolerant state), the inhibitory effects of clonidine on the synthesis of DOPA/NA (hippocampus, hypothalamus) and DOPA/DA (striatum) also were potentiated (35%-55%). In summary, we conclude that morphine addiction is associated with supersensitivity of 5-HT1A serotonin receptors and alpha2-adrenoceptors (autoreceptors and heteroreceptors) that modulate the synthesis of monoamines in brain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11882917     DOI: 10.1007/s00210-001-0508-8

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

Review 1.  Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.

Authors:  Wakako Fujita; Ivone Gomes; Lakshmi A Devi
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

2.  Sequential and opposing alterations of 5-HT(1A) receptor function during withdrawal from chronic morphine.

Authors:  Pierre-Eric Lutz; Amynah A Pradhan; Celia Goeldner; Brigitte L Kieffer
Journal:  Eur Neuropsychopharmacol       Date:  2011-03-12       Impact factor: 4.600

3.  Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine.

Authors:  Celia Goeldner; Pierre-Eric Lutz; Emmanuel Darcq; Thomas Halter; Daniel Clesse; Abdel-Mouttalib Ouagazzal; Brigitte L Kieffer
Journal:  Biol Psychiatry       Date:  2010-10-14       Impact factor: 13.382

4.  Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.

Authors:  Ana González-Cuello; M Victoria Milanés; Manuel Aviles; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-13       Impact factor: 3.000

5.  Effects of repeated exposure to MDMA on 5HT1a autoreceptor function: behavioral and neurochemical responses to 8-OHDPAT.

Authors:  Susan Schenk; Blaine Abraham; Dane Aronsen; Joyce Colussi-Mas; Jennifer Do
Journal:  Psychopharmacology (Berl)       Date:  2013-01-25       Impact factor: 4.530

6.  Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain.

Authors:  David Moranta; Susana Esteban; Jesús A García-Sevilla
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-16       Impact factor: 3.000

7.  Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.

Authors:  Kelly E Dunn; Elise M Weerts; Andrew S Huhn; Jennifer R Schroeder; David Andrew Tompkins; George E Bigelow; Eric C Strain
Journal:  Addict Biol       Date:  2018-10-08       Impact factor: 4.280

8.  Ergot alkaloids reduce circulating serotonin in the bovine.

Authors:  Eriton E L Valente; James L Klotz; Gyuchul Ahn; Kyle R McLeod; Hannah M Herzing; Mindy King; David L Harmon
Journal:  J Anim Sci       Date:  2020-12-01       Impact factor: 3.159

9.  Transgenerational influence of parental morphine exposure on pain perception, anxiety-like behavior and passive avoidance memory among male and female offspring of Wistar rats.

Authors:  Hamid Ahmadian-Moghadam; Mitra-Sadat Sadat-Shirazi; Fereshteh Seifi; Saba Niknamfar; Ardeshir Akbarabadi; Heidar Toolee; Mohammad-Reza Zarrindast
Journal:  EXCLI J       Date:  2019-11-05       Impact factor: 4.068

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.